Owner | Filings | Transaction Date | Type of Owner |
---|---|---|---|
ZANTE GREG | 0001264949 | Jan-04-2021 | officer: Chief Financial Officer |
Mancini Marianna | 0001838112 | Jan-04-2021 | officer: Chief Operating Officer |
Rouan Sarah Kathryn | 0001761366 | Jul-01-2019 | director |
Masamune Hiroko | 0001745341 | Jul-01-2018 | officer: Chief Development Officer |
Rowland Charles A Jr | 0001383292 | Jul-01-2017 | director |
LIGAND PHARMACEUTICALS INC | 0000886163 | Apr-13-2016 | 10 percent owner |
FOEHR MATTHEW W | 0001237556 | Apr-28-2015 | director |
SINGLETON J MATTHEW | 0001243514 | Apr-28-2015 | director |
Webster Stephen W | 0001438421 | Apr-28-2015 | director |
MORNEAU MICHAEL | 0001517780 | Apr-28-2015 | officer: Chief Financial Officer |
MACARTNEY LAWSON | 0001606831 | Apr-28-2015 | director |
Lian Brian | 0001614578 | Apr-28-2015 | director, officer: President & CEO |
Dinerman Michael | 0001614589 | Apr-28-2015 | officer: Chief Operating Officer |
Hanley Rochelle | 0001614595 | Apr-28-2015 | officer: Chief Medical Officer |
Coming soon!
Coming soon!
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Viking Therapeutics, Inc.
Filings | Format | Description | Filed/Effective | File/Film Number |
---|---|---|---|---|
ARS | Document | Annual report to security holders Acc-no: 0000950170-24-042275 (34 Act) Size: 774 KB |
Apr-05-2024 | 24826686 |
DEFA14A | Document | Additional definitive proxy solicitation materials Acc-no: 0000950170-24-042264 (34 Act) Size: 247 KB |
Apr-05-2024 | 24826564 |
DEF 14A | Document | Definitive proxy statements Acc-no: 0000950170-24-042251 (34 Act) Size: 3291 KB |
Apr-05-2024 | 24826464 |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001209191-24-005118 ( Act) Size: 6 KB |
Mar-27-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001209191-24-005117 ( Act) Size: 6 KB |
Mar-27-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001209191-24-005116 ( Act) Size: 6 KB |
Mar-27-2024 | |
8-K | Document | Current report filing Acc-no: 0000950170-24-036151 (34 Act) Size: 254 KB |
Mar-26-2024 | 24780882 |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001209191-24-004233 ( Act) Size: 6 KB |
Mar-04-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001209191-24-004232 ( Act) Size: 6 KB |
Mar-04-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001209191-24-004231 ( Act) Size: 6 KB |
Mar-04-2024 | |
8-K | Document | Current report filing Acc-no: 0000950170-24-024878 (34 Act) Size: 199 KB |
Mar-04-2024 | 24715510 |
424B5 | Document | Prospectus filed pursuant to Rule 424(b)(5) Acc-no: 0000950170-24-023848 (33 Act) Size: 815 KB |
Mar-01-2024 | 24709871 |
8-K | Document | Current report filing Acc-no: 0000950170-24-023838 (34 Act) Size: 604 KB |
Mar-01-2024 | 24709566 |
424B5 | Document | Prospectus filed pursuant to Rule 424(b)(5) Acc-no: 0000950170-24-021420 (33 Act) Size: 788 KB |
Feb-27-2024 | 24688616 |
8-K | Document | Current report filing Acc-no: 0000950170-24-020616 (34 Act) Size: 254 KB |
Feb-27-2024 | 24681925 |
SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000905148-24-000616 (34 Act) Size: 281 KB |
Feb-14-2024 | 24633550 |
SC 13G | Document | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001104659-24-022246 (34 Act) Size: 12 KB |
Feb-13-2024 | 24629911 |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001209191-24-003068 ( Act) Size: 4 KB |
Feb-09-2024 | |
144 | Document | Filing for proposed sale of securities under Rule 144 Acc-no: 0000103623-24-000023 (33 Act) Size: 5 KB |
Feb-09-2024 | 24614629 |
SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000315066-24-001571 (34 Act) Size: 8 KB |
Feb-09-2024 | 24612644 |
Recent 20 filings. View all Viking Therapeutics, Inc. filings
Very good communication and delivery made within the timeframe I was advised of
It's being easier working on the website. And I recommend, it's a great website
Huge help thank you for your help .. y'all make it so much easier
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
© 2022 CompaniesBIO.Com. All rights reserved. Operated by